vs

Side-by-side financial comparison of Iveda Solutions, Inc. (IVDA) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.

PAVmed Inc. is the larger business by last-quarter revenue ($996.0K vs $626.0K, roughly 1.6× Iveda Solutions, Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -258.6%, a 6724.4% gap on every dollar of revenue. On growth, PAVmed Inc. posted the faster year-over-year revenue change (25.9% vs -64.1%).

Iveda Solutions, Inc. is a technology provider specializing in cloud-based AI video surveillance, IoT-enabled smart sensing, and integrated smart city solutions. It serves public sector, enterprise, and education clients across North America and Asia, with core offerings covering remote security monitoring, smart facility management, and real-time data analysis tools for public safety use cases.

PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.

IVDA vs PAVM — Head-to-Head

Bigger by revenue
PAVM
PAVM
1.6× larger
PAVM
$996.0K
$626.0K
IVDA
Growing faster (revenue YoY)
PAVM
PAVM
+90.0% gap
PAVM
25.9%
-64.1%
IVDA
Higher net margin
PAVM
PAVM
6724.4% more per $
PAVM
6465.8%
-258.6%
IVDA

Income Statement — Q4 FY2025 vs Q3 FY2024

Metric
IVDA
IVDA
PAVM
PAVM
Revenue
$626.0K
$996.0K
Net Profit
$-1.6M
$64.4M
Gross Margin
3.6%
-38.7%
Operating Margin
-262.7%
-1162.4%
Net Margin
-258.6%
6465.8%
Revenue YoY
-64.1%
25.9%
Net Profit YoY
-7.1%
464.4%
EPS (diluted)
$-0.33
$1.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVDA
IVDA
PAVM
PAVM
Q4 25
$626.0K
Q3 25
$1.7M
Q2 25
$1.5M
Q1 25
$1.5M
Q4 24
$1.7M
Q3 24
$2.4M
$996.0K
Q2 24
$1.5M
$979.0K
Q1 24
$346.8K
$1.0M
Net Profit
IVDA
IVDA
PAVM
PAVM
Q4 25
$-1.6M
Q3 25
$-221.3K
Q2 25
$-564.2K
Q1 25
$-793.7K
Q4 24
$-1.5M
Q3 24
$-581.4K
$64.4M
Q2 24
$-599.0K
$-10.8M
Q1 24
$-1.3M
$-15.2M
Gross Margin
IVDA
IVDA
PAVM
PAVM
Q4 25
3.6%
Q3 25
31.3%
Q2 25
29.1%
Q1 25
19.5%
Q4 24
11.9%
Q3 24
17.1%
-38.7%
Q2 24
32.7%
-70.2%
Q1 24
52.5%
-72.7%
Operating Margin
IVDA
IVDA
PAVM
PAVM
Q4 25
-262.7%
Q3 25
-13.0%
Q2 25
-34.8%
Q1 25
-56.7%
Q4 24
-87.3%
Q3 24
-25.4%
-1162.4%
Q2 24
-39.7%
-1397.8%
Q1 24
-384.1%
-1389.7%
Net Margin
IVDA
IVDA
PAVM
PAVM
Q4 25
-258.6%
Q3 25
-13.4%
Q2 25
-36.9%
Q1 25
-53.8%
Q4 24
-86.7%
Q3 24
-24.2%
6465.8%
Q2 24
-39.0%
-1105.9%
Q1 24
-371.9%
-1506.1%
EPS (diluted)
IVDA
IVDA
PAVM
PAVM
Q4 25
$-0.33
Q3 25
$-0.07
Q2 25
$-0.20
Q1 25
$-0.28
Q4 24
$-0.60
Q3 24
$-0.27
$1.44
Q2 24
$-0.30
$-1.19
Q1 24
$-0.64
$-2.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVDA
IVDA
PAVM
PAVM
Cash + ST InvestmentsLiquidity on hand
$5.2M
$765.0K
Total DebtLower is stronger
$393.4K
Stockholders' EquityBook value
$4.8M
$-4.9M
Total Assets
$6.4M
$30.6M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVDA
IVDA
PAVM
PAVM
Q4 25
$5.2M
Q3 25
$3.3M
Q2 25
$1.6M
Q1 25
$2.5M
Q4 24
$2.6M
Q3 24
$3.6M
$765.0K
Q2 24
$2.9M
$25.5M
Q1 24
$3.9M
$25.5M
Total Debt
IVDA
IVDA
PAVM
PAVM
Q4 25
$393.4K
Q3 25
$306.4K
Q2 25
$365.3K
Q1 25
$340.8K
Q4 24
$376.2K
Q3 24
$545.9K
Q2 24
$564.0K
Q1 24
$480.0K
Stockholders' Equity
IVDA
IVDA
PAVM
PAVM
Q4 25
$4.8M
Q3 25
$3.8M
Q2 25
$1.5M
Q1 25
$1.7M
Q4 24
$2.5M
Q3 24
$4.1M
$-4.9M
Q2 24
$2.8M
$-73.9M
Q1 24
$3.3M
$-68.8M
Total Assets
IVDA
IVDA
PAVM
PAVM
Q4 25
$6.4M
Q3 25
$5.8M
Q2 25
$4.4M
Q1 25
$4.5M
Q4 24
$5.2M
Q3 24
$9.1M
$30.6M
Q2 24
$6.8M
$39.4M
Q1 24
$6.6M
$37.3M
Debt / Equity
IVDA
IVDA
PAVM
PAVM
Q4 25
0.08×
Q3 25
0.08×
Q2 25
0.25×
Q1 25
0.20×
Q4 24
0.15×
Q3 24
0.13×
Q2 24
0.20×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVDA
IVDA
PAVM
PAVM
Operating Cash FlowLast quarter
$-252.4K
$-8.9M
Free Cash FlowOCF − Capex
$-8.9M
FCF MarginFCF / Revenue
-892.5%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
-0.14×
TTM Free Cash FlowTrailing 4 quarters
$-45.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVDA
IVDA
PAVM
PAVM
Q4 25
$-252.4K
Q3 25
$-317.0K
Q2 25
$-1.3M
Q1 25
$-126.0K
Q4 24
$-889.8K
Q3 24
$-1.2M
$-8.9M
Q2 24
$-999.7K
$-11.7M
Q1 24
$-1.3M
$-13.1M
Free Cash Flow
IVDA
IVDA
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-889.8K
Q3 24
$-1.5M
$-8.9M
Q2 24
$-1.1M
$-11.7M
Q1 24
$-1.5M
$-13.2M
FCF Margin
IVDA
IVDA
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-51.1%
Q3 24
-64.1%
-892.5%
Q2 24
-72.6%
-1190.9%
Q1 24
-427.3%
-1302.1%
Capex Intensity
IVDA
IVDA
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
12.5%
0.6%
Q2 24
7.5%
0.3%
Q1 24
54.3%
4.2%
Cash Conversion
IVDA
IVDA
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.14×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons